Catalyst Wire Dossier Catalyst Wire Dossier

LDV/SOF fixed-dose combination

ledipasvir/sofosbuvir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LDV/SOF fixed-dose combination, covering 2014-11-17 to 2014-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects [Phase 2]

See pricing